[23] In addition, this receptor is the target of the thiazolidenidone class of medications that are used to improve insulin sensitivity and decrease risk for T2DM or control FBG in individuals diagnosed with T2DM. The gene discussed is INS; the disease is type 2 diabetes mellitus.